BridgeMD
Tests treatment safety and results for Multiple System Atrophy - Cerebellar Subtype (MSA-C)
Official title Efficacy and Safety of Transcranial dIrect Current stiMulation in Multiple System Atrophy-Cerebellar Variant
ClinicalTrials.gov ID: NCT06821256
What this study is testing
- What it's testing
- This is a double-blind, randomized, sham-controlled clinical trial that aim to verify the safety and the efficacy of anodal transcranial direct current stimulation (tDCS) cerebellar symptoms in Multiple System Atrophy type C (MSA).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 90
You may be able to join if
- Multiple system atrophy cerebellar variant according with the Movemente Disorder Society criteria (Wenning et al 2022)
- Ability to walk either indipendently or with a minimum support
You likely can't join if
- Presence of electrical stimulators (for example, pacemaker, Deep Brain Stimulation, DBS)
- Difficult in understanding Italian language
- Presence of severe sensory deficits (for example, visual or hearing impairments)
- History of drug abuse
- History of severe psychiatric disorders
- History of transient ischemic attacks
See the full eligibility criteria
- Multiple system atrophy cerebellar variant according with the Movemente Disorder Society criteria (Wenning et al 2022)
- Ability to walk either indipendently or with a minimum support
- Presence of electrical stimulators (for example, pacemaker, Deep Brain Stimulation, DBS)
- Difficult in understanding Italian language
- Presence of severe sensory deficits (for example, visual or hearing impairments)
- History of drug abuse
- History of severe psychiatric disorders
- History of transient ischemic attacks
- Cortical or sub-cortical vascular lesions
- Seizures or severe heart problems and previous neurosurgical operations
- Pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Salerno, Sa, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Salerno, Sa, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.